DoW Epilepsy Research Partnership Award
DoW Epilepsy Research Partnership Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 17 Aug 2026. Summary: The intent of the Epilepsy Research Program (ERP) Research Partnership Award is to support new or existing research partnerships focused on collaboratively addressing critical questions relevant to post-traumatic epilepsy (PTE) in a manner that would be unachievable through separate efforts…
Opportunity overview
- Project name
- DoW Epilepsy Research Partnership Award
- Donor
- Defense Health Agency Contracting Activity - DHACA
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is DoW Epilepsy Research Partnership Award?
DoW Epilepsy Research Partnership Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 17 Aug 2026. Summary: The intent of the Epilepsy Research Program (ERP) Research Partnership Award is to support new or existing research partnerships focused on collaboratively addressing critical questions relevant to post-traumatic epilepsy (PTE) in a manner that would be unachievable through separate efforts…
Who is funding DoW Epilepsy Research Partnership Award?
DoW Epilepsy Research Partnership Award is funded by Defense Health Agency Contracting Activity - DHACA.
When is the deadline to apply for DoW Epilepsy Research Partnership Award?
The application deadline is 17 Aug 2026 00:00 (UTC).
Where will the DoW Epilepsy Research Partnership Award project take place?
The project location(s) are: United States.
How can I apply for DoW Epilepsy Research Partnership Award?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.